Hazel Hunt - 11 Feb 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Issuer symbol
CORT
Transactions as of
11 Feb 2025
Net transactions value
-$5,307,837
Form type
4
Filing time
13 Feb 2025, 20:20:03 UTC
Previous filing
05 Aug 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $493,500 +150,000 +126% $3.29 268,581 11 Feb 2025 Direct
transaction CORT Common Stock Tax liability $5,801,337 -85,176 -32% $68.11 183,405 11 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (right to buy) Options Exercise $0 -150,000 -100% $0.000000 0 11 Feb 2025 Common Stock 150,000 $3.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 18, 2025.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.